title: The potential impact of pharmacogenetic testing on medication adherence.
abstract: Poor medication adherence is a well-known problem, particularly in patients with chronic conditions, and is associated with significant morbidity, mortality and health-care costs. Multi-faceted and personalized interventions have shown the greatest success. Pharmacogenetic (PGx) testing may serve as another tool to boost patients' confidence in the safety and efficacy of prescribed medications. Here, we consider the potential impact (positively or negatively) of PGx testing on medication-taking behavior.
authors.affiliation: Institute for Genome Sciences and Policy, Duke University, Durham, NC, USA.
authors.forename: S B
authors.initials: SB
authors.lastname: Haga
authors.forename: N M A
authors.initials: NM
authors.lastname: LaPointe
mesh_terms: D002908:Chronic Disease; D006801:Humans; D010349:Patient Compliance; D010597:Pharmacogenetics